Hypokinetic Movement Disorders

Similar documents
Disorders of Movement M A R T I N H A R L E Y N E U R O L O G Y

DIFFERENTIAL DIAGNOSIS SARAH MARRINAN

III./3.1. Movement disorders with akinetic rigid symptoms

Differential Diagnosis of Hypokinetic Movement Disorders

Parkinson s Disease in the Elderly A Physicians perspective. Dr John Coyle

Parkinson s Disease. Sirilak yimcharoen

Professor Tim Anderson

Evaluation of Parkinson s Patients and Primary Care Providers

Parkinson Disease. Lorraine Kalia, MD, PhD, FRCPC. Presented by: Ontario s Geriatric Steering Committee

Movement Disorders Will Garrett, M.D Assistant Professor of Neurology

Overview. Overview. Parkinson s disease. Secondary Parkinsonism. Parkinsonism: Motor symptoms associated with impairment in basal ganglia circuits

Professor Tim Anderson

An approach to movement disorders. Kailash Bhatia, DM, FRCP Professor of Clinical Neurology Institute of Neurology Queen Square, London

STEADY YOUR APPROACH TO TREMOR (OVERVIEW OF DIFFERENTIAL DIAGNOSIS)

Identification number: TÁMOP /1/A

Movement Disorders. Psychology 372 Physiological Psychology. Background. Myasthenia Gravis. Many Types

Parkinson s Disease Update. Presented by Joanna O Leary, MD Movement disorder neurologist Providence St. Vincent s

Pathogenesis of Degenerative Diseases and Dementias. D r. Ali Eltayb ( U. of Omdurman. I ). M. Path (U. of Alexandria)

Movement Disorders- Parkinson s Disease. Fahed Saada, MD March 8 th, th Family Medicine Refresher Course St.

VL VA BASAL GANGLIA. FUNCTIONAl COMPONENTS. Function Component Deficits Start/initiation Basal Ganglia Spontan movements

Atypical parkinsonism

Presented by Joanna O Leary, MD Providence St. Vincent Medical Center Movement Disorder Department

First described by James Parkinson in his classic 1817 monograph, "An Essay on the Shaking Palsy"

An Approach to Patients with Movement Disorders

Parkinson s Disease Initial Clinical and Diagnostic Evaluation. J. Timothy Greenamyre, MD, PhD

Parkinson s Disease and other related movement disorders a video guide to diagnosis

Transcranial sonography in movement disorders

PARKINS ON CENTER. Parkinson s Disease: Diagnosis and Management. Learning Objectives: Recognition of PD OHSU. Disclosure Information

Parkinson s Disease. Prevalence. Mark S. Baron, M.D. Cardinal Features. Clinical Characteristics. Not Just a Movement Disorder

Moving fast or moving slow: an overview of Movement Disorders

Movement Disorders. Eric Kraus, MD! Neurology!

Treatment of Parkinson s Disease: Present and Future

PARKINSON S PRIMER. Dr. Kathryn Giles MD, MSc, FRCPC Cambridge, Ontario, Canada

Parkinson s Disease: initial diagnosis, initial treatment & non-motor features. J. Timothy Greenamyre, MD, PhD

MAXIMIZING FUNCTION IN PARKINSON S DISEASE

Hubert H. Fernandez, MD

Update on functional brain imaging in Movement Disorders

Parkinson s Disease Update

Department of Neurology, Rigshospitalet, 9 Blegdamsvej, PAULSON, O.B. Involuntary Movements. Tohoku J. Exp. Med., 1990, 161,

A. General features of the basal ganglia, one of our 3 major motor control centers:

A. General features of the basal ganglia, one of our 3 major motor control centers:

Parts of the motor circuits

Update on Parkinson s disease and other Movement Disorders October 2018

Optimizing Clinical Communication in Parkinson s Disease:

Types of involuntary movements

Table of Contents. Preface... xi. Part I: Introduction to Movement Disorders

CN V! touch! pain! Touch! P/T!

Childhood Movement Disorders Alessandro Capuano, MD, PhD Federica Graziola, MD

Diagnosis and treatment of dystonia

Dr Barry Snow. Neurologist Auckland District Health Board

Phenomenology of Movement Disorders

Objectives. Distinguishing Parkinson s disease from other parkinsonian and tremor syndromes. Characteristics. Basal Ganglia Structures

La neurosonologia. Ecografia cerebrale e nuove applicazioni nelle malattie neurodegenerative. Nelle patologie degenerative e vascolari cerebrali

Basal ganglia Sujata Sofat, class of 2009

Early Clinical Features of Parkinson s Disease and Related Disorders. Dr. Alastair Noyce

Tremor 101. Objectives 9/30/2015. Importance of tremors

Diagnosis and treatment of dystonia

The motor regulator. 1) Basal ganglia/nucleus

Tremor. Mario Zappia. Università degli Studi di Catania

Dystonia: Title. A real pain in the neck. in All the Wrong Places

Visualization and simulated animations of pathology and symptoms of Parkinson s disease

10/13/2017. Disclosures. Deep Brain Stimulation in the Treatment of Movement Disorders. Deep Brain Stimulation: Objectives.

GENETICS AND TREATMENT OF DYSTONIA

Scott J Sherman MD, PhD The University of Arizona PARKINSON DISEASE

Faculty. Joseph Friedman, MD

FOUNDATION OF UNDERSTANDING PARKINSON S DISEASE

WELCOME. Parkinson s 101 for the Newly Diagnosed. Today s Topic: Parkinson s Basics presented by Cari Friedman, LCSW

Dementia Update. October 1, 2013 Dylan Wint, M.D. Cleveland Clinic Lou Ruvo Center for Brain Health Las Vegas, Nevada

Hunting for Huntington s

The Person: Dementia Basics

Evaluation and Management of Parkinson s Disease in the Older Patient

Involuntary Movements in Children and Adolescents: Is it Seizure, Tic or Something Else?

8/28/2017. Behind the Scenes of Parkinson s Disease

DEMENTIA and BPSD in PARKINSON'S DISEASE. DR. T. JOHNSON. NOVEMBER 2017.

Functional Distinctions

Objectives. RAIN Difficult Diagnosis 2014: A 75 year old woman with falls. Case History: First visit. Case History: First Visit

Extrapyramidal Motor System. Basal Ganglia or Striatum. Basal Ganglia or Striatum 3/3/2010

PARKINSON S DISEASE. Nigrostriatal Dopaminergic Neurons 5/11/16 CARDINAL FEATURES OF PARKINSON S DISEASE. Parkinson s disease

PARKINSON S DISEASE: current aspects of ETIOLOGY, DIAGNOSIS and TREATMENT. Dilek Ince Gunal, MD Assoc. Prof

Multiple System Atrophy

Prior Authorization with Quantity Limit Program Summary

Basal ganglia motor circuit

Corporate Medical Policy

M. Carranza M. R. Snyder J. Davenport Shaw T. A. Zesiewicz. Parkinson s Disease. A Guide to Medical Treatment

Movement disorders in childhood: assessment and diagnosis. Lucinda Carr

DISORDERS OF THE MOTOR SYSTEM. Jeanette J. Norden, Ph.D. Professor Emerita Vanderbilt University School of Medicine

Movement Disorders: A Brief Overview

Neurodegenerative Disease. April 12, Cunningham. Department of Neurosciences

Dementia. Stephen S. Flitman, MD Medical Director 21st Century Neurology

Tremor What is tremor? What causes tremor? What are the characteristics of tremor? What are the different categories of tremor?

Pietro Cortelli. IRCCS Istituto delle Scienze Neurologiche di Bologna DIBINEM, Alma Mater Studiorum - Università di Bologna

10th Medicine Review Course st July Prakash Kumar

Comprehensive Approach to DLB Management

Joint Session with ACOFP and Mayo Clinic. Parkinson's Disease: 5 Pearls. Jay Van Gerpen, MD

Neuroscience 410 Huntington Disease - Clinical. March 18, 2008

Lecture XIII. Brain Diseases I - Parkinsonism! Brain Diseases I!

Parkinson's Disease Center and Movement Disorders Clinic

Vague Neurological Disorders

Understanding Dystonia

Learnings from Parkinson s disease: Critical role of Biomarkers in successful drug development

Transcription:

Hypokinetic Movement Disorders Ariane Park, MD, MPH Assistant Professor-Clinical Division of Neurology The Ohio State University Wexner Medical Center Hypokinetic movement disorders Diminished voluntary movement unrelated to weakness or spasticity The most common of these disorders is forms of parkinsonism Photo by Arthur Londe from Nouvelle Iconographie de la Salpètrière, vol. 5., p.226 1

Classification of parkinsonism Primary Parkinson's disease Juvenile parkinsonism Secondary Infectious Drugs Toxins Vascular Trauma Metabolic Atypical parkinsonian syndromes Corticobasal degeneration (CBD) Progressive Supranuclear Palsy (PSP) Multiple System Atrophy (MSA) Lewy Body Dementia (LBD) Parkinson s Disease Second most common neurodegenerative condition next to Alzheimer s Disease 1%-2% of people over 60 Rare before 50 Prevalence increases with age Up to 4% in the highest age groups In the United States 630,000 people diagnosed in 2010 Prevalence likely to double by 2040 In 2010 national economic burden of PD > $14.4 billion De Lau LM, Breteler MM. Lancet Neurol 2006 Kowal, SL. Dall, TM et al. Mov Disorders 2013 2

Pathologic hallmarks Loss of dopaminergic neurons primarily in substantia nigra pars compacta By the time symptoms appear, SN has lost 60% of DA neurons and DA content of striatum is 80% of normal Proteinaceous inclusions in nerve cells and terminals, known as Lewy bodies and Lewy neurites respectively Alpha-synuclein major component Glial response in all area of brain where signs of neurodegeneration can be found Diagnostic testing In life, defined by clinical findings No diagnostic lab/imaging tests Insufficient evidence that urodynamics, autonomic testing, EMG, MRI, sonography and PET scanning is useful in differentiating PD from other forms of parkinsonism Levadopa challenge 3

DaTscan [123I] FP-CIT SPECT scan 2011 FDA approved to distinguish essential tremor vs parkinsonism Measures activity of dopamine transporter (DaT) Does NOT diagnose PD - Adjunct to patient workup to supplement, and not replace, neurological examination and clinical judgment PD, PSP, MSA and other parkinsonian syndromes all abnormal Needs trained interpreter UK Brain Bank criteria Inclusion criteria Bradykinesia At least one of the following: Muscular rigidity 4-6Hz rest tremor Postural instability not caused by primary visual, vestibular, cerebellar, or proprioceptive dysfunction Supportive criteria Unilateral onset Persistent asymmetry affecting side of onset most Rest tremor present Progressive disorder Excellent response (70-100%) to levodopa Levodopa-induced chorea Levodopa response for 5 yrs or more Clinical course of 10 yrs or more Hughes AJ et al. JNNP 1992; 55: 181-184. 4

Exclusion criteria for PD History of repeated strokes with stepwise progression of parkinsonian features History of repeated head injury History of definite encephalitis Neuroleptic treatment at onset of symptoms Sustained remission Strictly unilateral features after 3 yrs Exclusion criteria for PD Supranuclear gaze palsy Cerebellar signs Early severe autonomic involvement Early severe dementia with disturbances of memory, language, and praxis Presence of cerebral tumor or communicating hydrocephalus on imaging MPTP exposure 5

Rest tremor Presents at rest and usually improves when affected limb performs a motor tasks In 75% of pts is first motor manifestation Usually beings unilaterally Can occur intermittently and vary in intensity Rigidity Increased resistance to passive movement of limb segment Bradykinesia Early may be confined to distal muscles Later have difficulty rising from chair and generalized slowing of voluntary movements Facial, vocal and cognitive manifestations 6

Balance and gait problems Earliest sign is often decreased arm swing Gait initiation and turning can become difficult Freezing can occur when starting to walk, attempting to turn or approaching narrow and crowded spaces 7

8

Motor symptoms Non-motor symptoms Langston, JW. Ann Neurol 2006 Author: Aweith - (CC BY-SA 4.0) Non-motor features Neuropsychiatric symptoms Dementia Depression Anhedonia Apathy Anxiety Slowness of thought Psychosis Autonomic dysfunctions Neurogenic bladder Erectile dysfunction Constipation Fatigue -Sleep disturbances REM sleep disturbances Sleep fragmentation Excessive daytime sleepiness Nocturnal akinesia/tremor RLS/PLMS -Sensory symptoms Diminished sense of smell Pain Numbness Paresthesia 9

Atypical Parkinsonism Corticobasal Degeneration (CBD) Progressive Supranuclear Palsy (PSP) Multiple System Atrophy (MSA) Lewy Body Dementia (LBD) These diseases share common features: -Quicker progression -Poor response to levodopa -Early cognitive involvement (LBD, PSP) -Early problems with gait and balance (PSP, MSA) Atypical Parkinsonisms Corticobasal syndrome ~2,000 in US Progressive supranuclear palsy ~20,000 in US 50% show clumps of tau 25% show tau and amyloidbeta 20% show alpha-synuclein 5% involve other proteins clumps of tau Muscle jerks Dystonia Cognitive impairment Apraxia Tendency to fall backwards Restricted extraocular movements and saccades Mood and behavioral changes Speech and swallowing problems 10

Atypical Parkinsonisms Multiple system atrophy ~80,000 in US Lewy body dementia ~15,000 in US Gait instability Cognitive Dysarthria impairment/dementia Autonomic dysfunction Hallucinations Orthostatic Mood/behavioral hypotension changes Urinary issues Fluctuations in Constipation alertness Sexual function Hypersomnolence Temperature regulation Sleep issues How to treat No neuroprotective therapies for Parkinson s Disease or atypical parkinsonisms Levodopa usually first treatment for motor symptoms, but usually no robust or prolonged benefit in atypical parkinsonism Symptomatic management, assistive devices, PT, OT, social work, palliative Therapies against these proteins (alpha-synuclein, tau, amyloid-beta) are in clinical trial 11

Shake, rattle and roll: the hyperkinetic movement disorders Barbara Kelly Changizi, MD Assistant Professor-Clinical Division of Neurology The Ohio State University Wexner Medical Center Hypokinetic vs Hyperkinetic Bradykinesia Parkinsonian disorders Tremor Dystonia Tics Chorea 12

Dystonia DEFINITION: twisting repetitive movements or abnormal postures that arise from involuntary muscle contractions Focal Neck Eyes Limb Generalized Dystonia classification Classification on cause Primary Focal dystonia, Generalized childhood dystonias (DYT1, DYT6) Dystonia plus syndromes Dopamine responsive dystonia Rapid onset dystonia parkinsonism Myoclonus dystonia X-linked dystonia parkinsonism (DyT3) Secondary dystonia Due to trauma, stroke, drugs 13

Focal dystonia Cervical dystonia Torticollis Laterocollis Anterocollis Retrocollis Blepharospasm Writer s cramp Oromandibular dystonia Geste antagoniste in dystonia A PURPOSEFUL MOVEMENT THAT SUPPRESSES THE INVOLUNTARY DYSTONIC MOVEMENT Unique to dystonia Hand on side of face, touching back of head for torticollis Walking backwards or running may reduce leg dystonia Placing objects in mouth for orolingual dystonia 14

Task specific dystonia May be task specific Throwing a ball Writer s cramp Musician dystonia Leon Fleisher pianist Golfers Yips = jerking while putting Oppenheim dystonia Inherited primary dystonia -1/2000 Ashkenazi Jews 1/20,000 in non-jews Autosomal dominant TorsinA, GAG deletion 30% penetrance 50% of patients affected by age 9, onset > 40 rare Most start in arm or leg, then spread to neck Peculiar twisting of leg and foot when child walks forwards Eventual spread to generalized dystonia 15

Tics Unvoluntary production of movements or sounds Motor and phonic Tics tend to change in repertoire, and wax and wane over time Premonitory sensation Tingling, aching, itching, tension that takes place before the tic Suppressible Patients describe increasing inner tension while suppress tics, followed by rebound of tics Definite Tourette syndrome diagnostic criteria per the Tourette Syndrome Classification Study Group (TSCSG) Both multiple motor and one or more phonic tics present at some time during the illness, although not necessarily concurrently. Tics occur many times daily, nearly every day, or intermittently throughout a period of more than one year. Anatomic location, number, frequency, type, complexity, or severity of tics change over time Onset before age 21 Involuntary movements and noises cannot be explained by other medical conditions. Tics witnessed by a reliable examiner directly or recorded by videotape. Tourette syndrome classification study group. Definitions and classifications of tic disorders. Arch Neurol. 1993;50:1013-1016. 16

Video Tourette Tremor Tremor is the most common movement disorder in outpatient practice INVOLUNTARY, RHYTHMIC OSCILLATION of a body part RHYTHMIC, constant frequency AXIS of tremor Alternating contractions of reciprocally innervated/antagonist muscles 17

Classification of tremors Rest versus action Resting tremor in repose Action tremor = all tremor manifestations of body parts that are not at rest Kinetic occurs with movement Postural tremor in antigravity posture Task-specific (writing, golf tremor) Isometric (fist squeeze, orthostatic tremor) = voluntary contraction of muscles NOT accompanied by change in position of body part Frequency Parkinson 3 to 5 Hz ET 5 to 10 Hz Orthostatic tremor 12 to 18 Hz Holmes, cerebellar tremor, <= 4Hz ESSENTIAL TREMOR Upper limbs in 95% of patients Head 34% patients Face/jaw 7% patients Voice 12% Tongue 30% Trunk 5% Lower limbs 30% 18

Essential Tremor Bimodal age of onset peaks in second and sixth decades Up to 5% of population Family history in about 50% cases LINGO1 gene sequence variation association SLC1A2 glial glutamate transporter gene polymorphisms Rubral tremor Midbrain injury (stroke, trauma) Lesion of cerebello-thalamic projections: combined hit to superior cerebellar peduncle, substantia nigra, and red nucleus Damage to: Outflow pathway from cerebellum to motor thalamus Dopaminergic-thalamic system Tremor at rest, posture, and action SLOW <=4 Hz Ipsilateral dysmetria and dysdiadochokinesia Delay 1 to 24 months 19

Chorea Involuntary continual irregular and unsustained movements that flow randomly from one body part to another Motor impersistence Parakinesia: incorporate movement into voluntary action Lurching gait Irregular speech Huntington Disease CHOREA Starts with clumsiness/fidgetiness Progresses to frank chorea Chorea affects diaphragm, pharynx, larynx producing dysarthria and dysphagia Motor impersistence Later parkinsonism (akinetic rigid state) PSYCHIATRIC DZ Depression, psychosis DEMENTIA Executive dysfunction Eventual profound dementia EYE MOVEMENTS Slowed saccades (early sign) Delay in volitional saccades impaired smooth pursuit 20

Huntington Disease Genetic basis is expansion of a CAG repeat encoding part of the protein huntingtin on CHR4 Autosomal dominant, full penetrance Toxicity of mutant huntingtin protein Normal 15-32 CAG repeats > 38 repeats HD Higher number of repeats, the earlier onset (anticipation) Genetic testing commercially available Always do genetic counseling and neuropsych eval first Prevalence in 4 to 8 per 100,000 in Europe, North America, lower in non-europeans Atrophy of the striatum, especially caudate Wilson disease Wilson disease Autosomal recessive Hepatic copper transport protein ATP7B ATPase that binds copper and transports copper across cellular membranes using ATP Over 300 different mutations, 1/90 people ATP7B mutation leads to Decreased transport of copper from liver into bile COPPER EXCESS Impaired incorporation of copper into apocerulopalsmin, leads to diminished formation ceruloplasmin Low ceruloplasmin used diagnostically, but not important clinically Copper accumulates in liver, spills into the blood, deposits in the brain 21

Wilson disease Presents usually between age 10 and 25, but variable Liver disease (18 to 84% of patients) Neurologic symptoms (18 to 73%) Psychiatric symptoms (10 to 100%) Children typically present with liver disease Chronic active hepatitis Asymptomatic liver enzyme elevations Cirrhosis Acute liver failure Neurologic disease: can present with many movement disorders TEST ANYONE YOUNGER THAN 50 WITH MOVEMENT DISORDER FOR THIS Wilson disease: pathogenesis Wilson disease: pathogenesis Copper accumulates in liver Eventual liver damage from copper Copper leaks into the blood Elevation in free serum copper levels Note total serum levels may not be elevated due to low ceruloplasmin Copper deposits into the brain Brain eventually atrophic Putamen and caudate brown and shrunken Advanced: spongy degeneration of subcortical white matter and cortex 22

Wilson disease: clinical manifestations Dysarthria Dystonia Tremor Parkinsonism Ataxia Chorea Risus sardonicus: dystonia in facial muscles Seizures Hyperreflexia Kaiser Fleischer rings Copper in cornea Video Wilson disease 23